Psyence Group Inc.
CA$0.12+CA$0.01 (+9.09%)
Psyence Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.0% below the high.
TSXV · PHA.V · CAD
Stock price, earnings
Quote as of Jun 23, 2026, 03:17 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Premier Health of America Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.31% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Premier Health of America Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Premier Health of America Inc. is a specialized Canadian enterprise dedicated to providing comprehensive healthcare services. The company offers both staffing solutions and outsourced operational support to meet diverse healthcare demands across the nation. Its service portfolio extends to health consulting, professional nursing care, and general healthcare provision, particularly for remote communities. Additionally, it manages medical transport services and operates Code Bleu, an agency specializing in the recruitment and placement of various healthcare professionals, including nurses, caregivers, and dental and other medical support staff. All its services are efficiently delivered and managed via PSweb, the company's proprietary Customer Relationship Management platform. Premier Health caters to a broad spectrum of clients, from government bodies and corporations to individual patients, public and private hospitals, medical clinics, and retirement residences. Founded in 2003, the company's main headquarters are located in Blainville, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q3 2024 | Aug 22, 2024 | -CA$0.05-600.0% vs estimate | CA$41.48M-11.55% vs estimate |
|---|
| Q2 2024 | May 27, 2024 | -CA$0.02-500.0% vs estimate | CA$46.28M+7.12% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.12+CA$0.01 (+9.09%)
Psyence Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.0% below the high.
CA$0.13CA$0.00 (0.0%)
Copland Road Capital Corporation’s quoted price sits in the lower half of its reported 52-week range, 33.33% below the high.
CA$0.10CA$0.00 (0.0%)
Entheon Biomedical Corp.’s quoted price sits in the lower half of its reported 52-week range, 77.78% below the high.
CA$0.01+CA$0.01 (+100.0%)
RAMM Pharma Corp.’s quoted price sits in the lower half of its reported 52-week range, 96.0% below the high.
CA$0.22-CA$0.01 (-4.35%)
Captor Capital Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.28% below the high.
CA$0.09-CA$0.02 (-15.0%)
Doseology Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.5% below the high.
$0.01$0.00 (0.0%)
Ovation Science Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.13% below the high.
$0.02$0.00 (0.0%)
EGF Theramed Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 87.43% below the high.